human glutathione synthetase inhibitor Participation in the Prevention of Cardiovascular Diseases 5-Oxoprolinuria as a Cause for

In order to reflect the exposure to the sum of all derivatives, pharmacokinetics of cobalamins-(III) (i.e., cobalamin-(III) entity without specific ligand) were investigated instead of hydroxocobalamin alone, using the concentration unit g eq/mL

Alternative administration strategies, such as sublingual delivery and advanced transdermal formulations, are being explored to circumvent traditional absorption limitations

taking notes in the drug instruction: intramuscular injection is limited to use when administration is required by this route and repeated injections at the same site should be avoided

Longer follow-up of our cohort for cardiometabolic and neurodevelopmental status will allow us to determine whether these other important child outcomes are affected by maternal supplementation during pregnancy and early lactation